Although mutation of EGF family ligands was not documented, the ligands are frequently expressed, and often co-expressed in breast, colon, lung, ovarian, gastric and prostate carcinomas (Normanno et al, 2006; De Luca et al, 2008). The gene discussed is EGF; the disease is prostate carcinoma.